2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Muscle Atrophy: new trials by email Literature Review of Muscle Atrophy trials Research Report on Muscle Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. IMM01-STEM - Muscle Atrophy | Phase 1 / Phase 2 | Completed | Immunis, Inc. | 13 | 2022-09-13 | 2026-09-09 |
| Electrical Stimulation for Critically Ill Covid-19 Patients Electrical Stimulation, Electrical Stimulation - Sham - Covid19, Muscle Atrophy | Phase 1 | Completed | Baylor College of Medicine | 19 | 2020-12-22 | 2023-02-16 |
| Safety Study of HPP593 in Subjects During and After Limb Immobilization HPP593, Placebo - Muscle Atrophy, Hypodynamia | Phase 1 | Terminated | High Point Pharmaceuticals, LLC. | 24 | 2012-01-01 | 2014-07-15 |
Muscular Atrophy (3) · COVID-19 (1) · Hypokinesia (1) · Muscle Weakness (1)
Atrophy (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Neuromuscular Manifestations (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Dyskinesias (1) · Infections (1) · Lung Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nidovirales Infections (1)
Baylor College of Medicine (1) · High Point Pharmaceuticals, LLC. (1) · Immunis, Inc. (1)
United States (3)
Shulin Wang, M.D. (1) · Tom Lane, PhD (1)